Chu et al. [74], who also showed a reduced proliferative state after E-cadherin knockdown in the human breast cancer cell lines MARY-X and SUM149, found that higher levels of E-cadherin in basal breast cancers were associated with poorer outcome, consistent with our observations in luminal B tumors (Fig. 10). This evidence concerns the gene CDH1 and breast carcinoma.